|
Delayed
Nasdaq
18:22:34 20/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 10.14 USD | +0.15% |
|
-6.93% | +64.96% |
| 08-14 | ImmuCell Corporation, Q2 2026 Earnings Call, Aug 14, 2026 | |
| 08-13 | ImmuCell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMMUCELL CORPORATION | Other Pharmaceuticals | +0.15% | -6.93% | +64.96% | +67.89% | +9.68% | 92M |  |  | |
- Stock Market
- Stocks
- ICCC Stock
- Charts ImmuCell Corporation
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
